Total Occlusion Study of Canada - TOSCA

May 15, 2002
Font Size
A
A
A
Date Presented:
01/01/1999
Date Published:
01/01/1999
Date Updated:
05/15/2002
Original Posted Date:
05/15/2002
References

Description:

Prospective, multicenter, randomized trial of primary stenting vs. balloon angioplasty in patients with symptomatic nonacute total occlusion (TIMI grade 0/1 flow) of native coronary arteries.

Hypothesis:

To determine whether routine stenting improves late complete patency of recanalize total coronary artery occlusions.

Study Design

Study Design:

Patients Screened: 1118
Patients Enrolled: 410
NYHA Class: Nort reported
Mean Follow Up: 6 months
Mean Patient Age: 18-80 (mean 58)
Female: 18%
Mean Ejection Fraction: mean 60%

Patient Populations:

nonacute total occlusion (TIMI grade 0/1 flow) of native coronary arteries able to accomodate a balloon of 3 mm or greater diameter

Exclusions:

<72 hours since onset of ST segment elevation, extensive lesion-related thrombus (TIMI thrombus grade 3 or 4), occlusions previously revascularized by patent bypass grafts, uncontrolled heart failure or shock, patient unwilling or unsuitable for 6 month angiography, patient of child-bearing potential, and inability to cross occlusion with guidewire

Primary Endpoints:

failure of sustained TIMI grade 3 flow at 6 months (confirmed by angiography),

Secondary Endpoints:

repeat revascularization, adverse cardiovascular events, and restenosis (>50% diameter stenosis on angiography)

Drug/Procedures Used:

Primary stenting (with heparin-coated 15 mm long PS-153 Palmaz-Schatz stent) vs. balloon angioplasty. Randomization occurred after successful placement of a guidewire across the occlusion and was stratified by duration of occlusion (≤6 weeks vs. >6 weeks/unknown). Aspirin and ticlopidine per investigator.

Principal Findings:

The overall incidence of the primary end point, failure of sustained TIMI grade 3 flow at 6 months (confirmed by angiography), was significantly lower in the stent group (10.9% vs. 19.5%; p = 0.024). The stent group also had a lower restenosis rate (<50% diameter stenosis; 55% vs. 70%, p < 0.01) and less target vessel revascularization at 6 months (8.4% vs 15.4%, p = 0.03). The incidence of adverse cardiovascular events was similar in the two groups(23.3%, 23.6%).

Interpretation:

Stenting is superior to PTCA for nonacute total coronary occlusions.

References:

Circulation 1999;100:236–242.

Keywords: Research Personnel, Heparin, Ticlopidine, Constriction, Pathologic, Coronary Occlusion, Angioplasty, Balloon, Coronary, Stents


< Back to Listings